Pillar · Biotech Investing
Biotech Due Diligence Checklist: How to Evaluate a Drug Pipeline and Probability of Approval
Most biotech investors skip due diligence and pay the price. This step-by-step checklist walks you through everything yo...
Start here
Pillar · Clinical Readouts
How to Read Biotech Clinical Trial Data: Phase 1, 2, 3 Results Explained for Investors
Clinical trial data is the single most important factor in biotech investing, but most investors struggle to read it. Th...
FDA & PDUFA Calendar
List of 10 Potential Deals in Q1 2024 for Small and Mid-Cap Biotech and Pharma Companies
Argenx, a Belgian biotechnology company (ARGX), is reportedly interested in acquiring Akari Therapeutics, a British biotechnology company (AKTX), in a deal that...
FDA & PDUFA Calendar
Vertex and CRISPR Therapeutics: Transformative Milestone with CASGEVY™ Authorization for Sickle Cell Disease and Beta Thalassemia
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) marked a significant milestone as the United Kingdom (U.K.) Medicines ...
FDA & PDUFA Calendar
Top 10 Biotech Companies Pioneering the Future of Healthcare
The biotechnology industry is a dynamic and rapidly evolving field, offering a diverse range of investment opportunities for individuals with varying risk appet...
FDA & PDUFA Calendar
BiopharmaWatch FDA Calendar Guide: Track Every Biotech Catalyst and PDUFA Date in Real Time
A PDUFA date is the deadline the FDA sets itself to decide on a drug application, and it is the most tradeable date in biotech. This guide explains what the dat...
FDA & PDUFA Calendar
Setback for Galera Therapeutics in Pursuit of Cancer Treatment
In the realm of biopharmaceutical innovation, the pursuit of groundbreaking cancer therapies often presents a challenging journey. Galera Therapeutics, a pionee...
FDA & PDUFA Calendar
The Decline of SAVA Stock: Unpacking Cassava Sciences' Current Challenges
Investors have been closely monitoring Cassava Sciences' (SAVA) stock, as it experienced a significant downturn recently. This plunge in stock value is primaril...
Biotech Investing
Neurology Investing Strategies: How to Leverage FDA Catalysts for Maximum Alpha
The neurology sector presents some of biotech’s most explosive opportunities. These are driven by high-risk, high-reward clinical events in Alzheimer’s, Parkins...
Biotech Investing
Systemic Biotech Investing: Emerging Catalysts and Investor Takeaways
Systemic and miscellaneous biotech areas cover rare or multi organ conditions with unique catalysts. Explore benchmarks, case studies, and investor strategies i...
Biotech Investing
Immunology Biotech Investing: Key Catalysts and Investor Insights
Immunology biotech stocks often move sharply on pivotal data from immune system targeting therapies. Explore benchmarks, case studies, and investor strategies....